These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12176567)

  • 1. Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition.
    Suwelack B; Kempkes-Koch M; Kobelt V; Hillebrand U; Matzkies F; Gerhardt U; Hohage H
    Transplant Proc; 2002 Aug; 34(5):1763-6. PubMed ID: 12176567
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.
    Martínez-Castelao A; Hueso M; Sanz V; Rejas J; Sarrias J; Alsina J; Grinyó JM
    Transplant Proc; 2002 Feb; 34(1):403-6. PubMed ID: 11959345
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
    Zivko M; Kusec R; Galesić K
    Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients.
    Kim W; Lee S; Kang SK; Yu HC; Cho BH; Park SK
    Transplant Proc; 2002 Dec; 34(8):3223-4. PubMed ID: 12493427
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
    Nakache R; Weinbroum A; Merhav H; Katz P; Kaplan E
    Transplant Proc; 2001 May; 33(3):2294-5. PubMed ID: 11377533
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
    van der Kleij FG; Schmidt A; Navis GJ; Haas M; Yilmaz N; de Jong PE; Mayer G; de Zeeuw D
    Kidney Int Suppl; 1997 Dec; 63():S23-6. PubMed ID: 9407415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients.
    van der Kleij FG; Navis GJ; Gansevoort RT; Heeg JE; Scheffer H; de Zeeuw D; de Jong PE
    Nephrol Dial Transplant; 1997; 12 Suppl 2():42-6. PubMed ID: 9269699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion/Deletion polymorphism of Angiotensin-converting enzyme as a risk factor for chronic allograft nephropathy.
    Fedor R; Asztalos L; Löcsey L; Szabó L; Mányiné IS; Fagyas M; Lizanecz E; Tóth A
    Transplant Proc; 2010; 42(6):2304-8. PubMed ID: 20692468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
    Bhatnagar V; O'Connor DT; Schork NJ; Salem RM; Nievergelt CM; Rana BK; Smith DW; Bakris GL; Middleton JP; Norris KC; Wright JT; Cheek D; Hiremath L; Contreras G; Appel LJ; Lipkowitz MS
    J Hypertens; 2007 Oct; 25(10):2082-92. PubMed ID: 17885551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
    Małyszko J; Małyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3069-72. PubMed ID: 19857679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.
    Danilov SM; Tovsky SI; Schwartz DE; Dull RO
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):374-386. PubMed ID: 28587581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.
    Park HC; Choi HY; Kim BS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
    Kidney Blood Press Res; 2006; 29(4):216-24. PubMed ID: 16960460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
    Broekroelofs J; Stegeman CA; Navis G; Tegzess AM; De Zeeuw D; De Jong PE
    J Am Soc Nephrol; 1998 Nov; 9(11):2075-81. PubMed ID: 9808093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease.
    Haas M; Yilmaz N; Schmidt A; Neyer U; Arneitz K; Stummvoll HK; Wallner M; Auinger M; Arias I; Schneider B; Mayer G
    Kidney Blood Press Res; 1998; 21(1):66-9. PubMed ID: 9661139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
    Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
    J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
    Ha SK; Yong Lee S; Su Park H; Ho Shin J; Jung Kim S; Hun Kim D; Rae Kim K; Yung Lee H; Suk Han D
    Nephrol Dial Transplant; 2000 Oct; 15(10):1617-23. PubMed ID: 11007831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison of angiotensin-converting enzyme inhibitors with calcium antagonists in renal transplant patients under cyclosporin treatment.
    Colak T; Emiroğlu R; Karakayali H; Bilgin N; Haberal M
    Transplant Proc; 2001 Aug; 33(5):2774-5. PubMed ID: 11498155
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of angiotensin-converting enzyme gene of donor and recipient on the function of transplanted kidney.
    Kabat-Koperska J; Baśkiewicz-Masiuk M; Safranow K; Gołembiewska E; Paczkowska E; Mikłaszewicz A; Kedzierska K; Giedrys-Kalemba S; Machaliński B; Ciechanowski K
    Transplant Proc; 2005 Mar; 37(2):755-9. PubMed ID: 15848522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme gene polymorphism in chronic allograft nephropathy.
    Biselli PM; Abbud-Filho M; Ferreira-Baptista MA; de Alvarenga MP; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Transplant Proc; 2006 Jun; 38(5):1327-8. PubMed ID: 16797293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.